Difference between revisions of "WSI22-117-Case-7"

From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |subject=BWH |intent=order |category=PGY2 |occurrenceDateTime=2022/09/02 12:00 |basedOn=WSI22-117 |priority=routine |code=apdidactic |orderDetail=case |au...")
 
Line 14: Line 14:
 
|performer=BQ01
 
|performer=BQ01
 
|bodySite=ENDOMETRIUM; CURETTAGE
 
|bodySite=ENDOMETRIUM; CURETTAGE
|reasonCode=Same patient as Case 6, but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels) ; offered chemo or 2nd curettage (elected the later).
+
|reasonCode=Same patient as Case 6, but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
}}
 
}}

Revision as of 14:14, August 24, 2022

WSI22-117-Case-7
Same patient as Case 6, but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
Retained Partial Hydatidiform Mole
August 20, 2024 12:00:00 PM